Principal Financial Group Portfolio holdings
Principal Financial Group, founded in 1879 as the Bankers Life Association by Edward Temple and headquartered in Des Moines, Iowa, is a global financial services firm specializing in retirement solutions, insurance, and asset management, overseeing more than $709 billion in assets under management as of late 2024. Serving over 62 million customers across individuals, businesses, and institutions, Principal offers 401(k) plans, group insurance (life, disability, dental), annuities, and investment products through its Principal Global Investors arm, with a strong focus on U.S. and international markets like Asia and Latin America. Known for its stability and customer-centric approach, the publicly traded company (NASDAQ: PFG) under CEO Dan Houston has expanded through acquisitions like Wells Fargo’s retirement business in 2019, emphasizing long-term financial security. With a workforce of over 19,000 and a legacy of resilience, Principal remains a trusted name in retirement and wealth management.
Top Buys
| 1 |
Brookfield
BN
|
$186M |
| 2 |
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
|
$166M |
| 3 |
HEICO Class A
HEI.A
|
$145M |
| 4 |
Ventas
VTR
|
$113M |
| 5 |
Cemex
CX
|
$111M |
Top Sells
| 1 |
Microsoft
MSFT
|
$285M |
| 2 |
TransDigm Group
TDG
|
$203M |
| 3 |
Verizon
VZ
|
$174M |
| 4 |
Moody's
MCO
|
$167M |
| 5 |
Digital Realty Trust
DLR
|
$161M |
Sector Composition
| 1 | Technology | 18.33% |
| 2 | Real Estate | 15.51% |
| 3 | Financials | 14.64% |
| 4 | Industrials | 11.45% |
| 5 | Consumer Discretionary | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Heron Therapeutics
HRTX
$204M
| $39.1K | ﹤0.01% |
33,694
+2,800
| +9% | +$3.25K |
|
2377
FTAI Infrastructure
FIP
$522M
| $38.8K | ﹤0.01% |
+10,507
| New | +$38.8K |
|
2378
C4 Therapeutics
CCCC
$177M
| $38.3K | ﹤0.01% |
13,917
+1,124
| +9% | +$3.09K |
|
2379
Gevo
GEVO
$411M
| $37.7K | ﹤0.01% |
24,831
+2,656
| +12% | +$4.04K |
|
2380
Praxis Precision Medicines
PRAX
$947M
| $36.5K | ﹤0.01% |
31,771
+12,700
| +67% | +$14.6K |
|
|
EU
2381
enCore Energy
EU
$440M
| $36.2K | ﹤0.01% |
+15,034
| New | +$36.2K |
|
|
NVTA
2382
DELISTED
Invitae Corporation
NVTA
| $34.6K | ﹤0.01% |
30,600
+2,731
| +10% | +$3.09K |
|
2383
Gannett
GCI
$592M
| $34.3K | ﹤0.01% |
15,261
-898,630
| -98% | -$2.02M |
|
2384
Summit Therapeutics
SMMT
$17.7B
| $34.3K | ﹤0.01% |
+13,679
| New | +$34.3K |
|
2385
Ocugen
OCGN
$315M
| $33.5K | ﹤0.01% |
61,761
+1,092
| +2% | +$593 |
|
2386
SES AI
SES
$395M
| $32.7K | ﹤0.01% |
+13,394
| New | +$32.7K |
|
2387
Torrid Holdings
CURV
$221M
| $31.9K | ﹤0.01% |
11,364
-827
| -7% | -$2.32K |
|
2388
Outlook Therapeutics
OTLK
$38.4M
| $31.9K | ﹤0.01% |
18,311
+1,373
| +8% | +$2.39K |
|
2389
Nkarta
NKTX
$149M
| $31.8K | ﹤0.01% |
14,505
+3,618
| +33% | +$7.92K |
|
2390
Adicet Bio
ACET
$60M
| $30.8K | ﹤0.01% |
12,695
-3,673
| -22% | -$8.93K |
|
2391
Nektar Therapeutics
NKTR
$557M
| $30.5K | ﹤0.01% |
53,034
-1,107,896
| -95% | -$637K |
|
|
VRAY
2392
DELISTED
ViewRay, Inc.
VRAY
| $29.8K | ﹤0.01% |
84,746
+24,980
| +42% | +$8.8K |
|
|
TSP
2393
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $29.1K | ﹤0.01% |
17,540
+1,969
| +13% | +$3.27K |
|
2394
Energy Vault
NRGV
$335M
| $28.4K | ﹤0.01% |
+10,409
| New | +$28.4K |
|
2395
Forge Global Holdings
FRGE
$242M
| $28.3K | ﹤0.01% |
+11,664
| New | +$28.3K |
|
|
PTRA
2396
DELISTED
Proterra Inc. Common Stock
PTRA
| $28.2K | ﹤0.01% |
23,518
-1,097
| -4% | -$1.32K |
|
2397
SelectQuote
SLQT
$372M
| $28.2K | ﹤0.01% |
14,443
-1,016
| -7% | -$1.98K |
|
2398
BlackSky Technology
BKSY
$594M
| $27.9K | ﹤0.01% |
+12,550
| New | +$27.9K |
|
2399
Nuvation Bio
NUVB
$1.02B
| $27.8K | ﹤0.01% |
15,468
-33,245
| -68% | -$59.8K |
|
2400
Inovio Pharmaceuticals
INO
$129M
| $27.4K | ﹤0.01% |
61,331
-7,812
| -11% | -$3.49K |
|